drugset / Trial / NCT04500496
Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy
RandomizedParallel-groupOpen-labelPrevention
Summary
To compare the effectiveness of vaginal dinoprostone and vaginal Isonicotinic acid hydrazide in minimizing the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-12-30
- Completion
- 2022-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dinoprostone | Other / unclassified | 3 mg | Intravenous |
| Subject | INH | Unknown | 900 mg | Intravenous |
Indications
No indication recorded.